AstraZeneca has started work with Oxford University to adapt its coronavirus vaccine against new strains of the virus.
The company says a trial suggests it only has "limited" effectiveness against the South African variant.
It hopes to have an adapted jab ready in the Autumn.
Dr David Nabarro from the World Health Organisation says this is something we need to get used to.